Clinical Trial Update: Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ISOVUE-250 and VISIPAQUE 270 for motion artifact and pain during peripheral digital subtraction angiography; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ISOVUE-250 (iohexol)
• VISIPAQUE 270 (iodixanol)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Peripheral Arterial Occlusive Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-04-18